CTS (CTS)
(Delayed Data from NYSE)
$45.49 USD
+1.72 (3.93%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $45.48 -0.01 (-0.02%) 7:58 PM ET
4-Sell of 5 4
C Value D Growth B Momentum C VGM
Income Statements
Fiscal Year end for CTS Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 550 | 587 | 513 | 424 | 469 |
Cost Of Goods | 360 | 376 | 328 | 285 | 311 |
Gross Profit | 191 | 211 | 185 | 139 | 158 |
Selling & Adminstrative & Depr. & Amort Expenses | 116 | 118 | 108 | 94 | 104 |
Income After Depreciation & Amortization | 75 | 93 | 76 | 45 | 54 |
Non-Operating Income | 3 | -10 | -135 | 4 | -1 |
Interest Expense | 3 | 2 | 2 | 3 | 3 |
Pretax Income | 75 | 81 | -61 | 45 | 50 |
Income Taxes | 15 | 21 | -19 | 11 | 14 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 61 | 60 | -42 | 35 | 36 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 61 | 60 | -42 | 35 | 36 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 104 | 123 | 103 | 72 | 78 |
Depreciation & Amortization (Cash Flow) | 29 | 30 | 27 | 27 | 25 |
Income After Depreciation & Amortization | 75 | 93 | 76 | 45 | 54 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 31.58 | 32.24 | 32.33 | 32.58 | 33.11 |
Diluted EPS Before Non-Recurring Items | 2.22 | 2.46 | 1.12 | 1.12 | 1.45 |
Diluted Net EPS (GAAP) | 1.92 | 1.85 | -1.30 | 1.06 | 1.09 |
Fiscal Year end for CTS Corporation falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 124.69 | 134.55 | 145.18 | 145.99 |
Cost Of Goods | NA | 82.63 | 88.15 | 94.44 | 94.34 |
Gross Profit | NA | 42.06 | 46.40 | 50.74 | 51.65 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 25.81 | 28.21 | 32.31 | 29.48 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 16.25 | 18.19 | 18.43 | 22.17 |
Non-Operating Income | NA | 2.19 | 1.55 | -1.53 | 1.23 |
Interest Expense | NA | 0.82 | 1.00 | 0.82 | 0.69 |
Pretax Income | NA | 17.63 | 18.74 | 16.08 | 22.71 |
Income Taxes | NA | 2.31 | 4.77 | 3.18 | 4.37 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 15.32 | 13.97 | 12.90 | 18.34 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 15.32 | 13.97 | 12.90 | 18.34 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 31.24 | 31.51 | 31.69 | 31.89 |
Diluted EPS Before Non-Recurring Items | NA | 0.47 | 0.54 | 0.59 | 0.61 |
Diluted Net EPS (GAAP) | NA | 0.49 | 0.44 | 0.41 | 0.58 |